copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
English Home - EMD Serono EMD Serono is a specialty innovator that helps create, improve and prolong lives for people living with infertility, multiple sclerosis and cancer
About EMD Serono: The Healthcare Business of Merck KGaA, Darmstadt . . . At EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U S , we work to transform lives by developing and delivering meaningful therapies, and working to truly understand and respond to the therapeutic and support needs of individual patients
Who we are - Company | EMD Serono At EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U S , we aspire to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer
Global Organization - EMD Serono EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada This connection to our global business allows us to leverage resources that optimize the delivery of products and services to customers and patients in the U S
Research - EMD Serono EMD Serono researchers strive to identify novel scientific opportunities that may translate into tangible value for patients living with serious unmet medical needs
Fertility - EMD Serono EMD Serono has a 25+ year legacy in helping people who are struggling to grow their family Discover our commitment to supporting families impacted by infertility
Neurology Immunology - EMD Serono At EMD Serono, we have a long-standing legacy in neurology and immunology, with vast R D and commercial experience in multiple sclerosis over more than 20 years
History - EMD Serono Today Today, Merck KGaA, Darmstadt, Germany holds the global rights to the "Merck" name and brand The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials Learn More
Expertise - EMD Serono EMD Serono has a proven legacy of delivering meaningful therapies for people living with difficult-to-treat diseases Explore our solutions
2025-06-11 Enpatoran Phase 2 Data from Cohort B in SLE - EMD Serono EMD Serono today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an investigational, oral, novel TLR7 8 inhibitor in systemic lupus erythematosus (SLE)